The UCLA Prostate Cancer Index

Development, Reliability, and Validity of a Health-Related Quality of Life Measure

Published in: Medical Care, v. 36, no. 7, July 1998, p. 1002-1012

Posted on RAND.org on January 01, 1998

by Mark Litwin, Ron D. Hays, Arlene Fink, Patricia A. Ganz, Barbara Leake, Robert H. Brook

Read More

Access further information on this document at www.jstor.org

This article was published outside of RAND. The full text of the article can be found at the link above.

The need for accurate measures of health-related quality of life (HRQOL) in men treated for prostate cancer is of paramount importance because patients may survive for many years after their diagnosis. Hence, interest has increased in choosing treatments that optimize both the quality and quantity of life in patients with this disease. This study sought to develop and evaluate a self-administered, multi-item, disease-specific instrument to capture the health concerns central to the quality of life of men treated for early stage prostate cancer. The UCLA Prostate Cancer Index performed well in this population of older men with and without prostate cancer. It demonstrated good psychometric properties and appeared to be well understood and easily completed. The high response among patients suggests that these men especially are interested in addressing both the general and disease-specific concerns that impact their daily quality of life.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.